Prakt. lékáren. 2010; 6(2): 68-72

Local drugs for oral mucosa diseases

PharmDr.Jan Gajdziok, Eliška Tajovská, PharmDr.Martina Bajerová, PharmDr.Zuzana Chalupová, Ph.D.
Ústav technologie léků, FF VFU Brno

The article builds on previously published issue about diseases of the oral mucosa. It is focused on the possibility of specific pharmacotherapeutic

intervention to mucosal diseases by local therapy with particular emphasis on local antiseptics, non-steroidal anti-inflammatory

drugs, corticosteroids, topical antibiotics, chemotherapeutics, and antifungals.

Keywords: oral mucosa diseases, local antiseptics, non-steroidal anti-inflammatory drugs, corticosteroids, topical antibiotics and chemotherapeutics

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gajdziok J, Tajovská E, Bajerová M, Chalupová Z. Local drugs for oral mucosa diseases. Praktické lékárenství. 2010;6(2):68-72.
Download citation

References

  1. Dizman B, Badger JC, Elasri MO, Mathias LJ. Antibacterial fluoromicas: A novel delivery medium. Appl Clay Sci 2007; 38: 57-63. Go to original source...
  2. Hrenovic J, Ivankovic T, Sekovanic, Rozic M. Toxicity of dodecylpyridinium and cetylpyridinium clorides against phosphateaccumulating bacterium. Cent Eur J Biol 2008; 3: 143-148. Go to original source...
  3. Automatizovaný informační systém léčivých přípravků (AISLP), verze platná k 1. 4. 2008.
  4. Sütterlin H, Alexy R, Kümmerer K. The toxicity of the quaternary ammonium compound benzalkonium chloride alone and in mixtures with other anionic compounds to bacteria in test systems with Vibrio fischeri and Pseudomonas putida. Ecotoxicol Environ Safety 2008; 71: 498-505. Go to original source... Go to PubMed...
  5. Busscher HJ, White DJ, Atema-Smit J, et al. Surfactive and antibacterial activity of cetylpyridinium chloride formulations in vitro and in vivo. J Clin Periodontol 2008; 35: 547-554. Go to original source... Go to PubMed...
  6. Kim SE, Shim KM, Yoo KH, et al. The Effect of Cetylpyridinium Chloride on Halitosis and Periodontal Disease-related Parameters in Dogs. Biotechnol Bioprocess Eng 2008; 13: 252-255. Go to original source...
  7. Díaz-Ramón L, Aguirre A, Ratón-Nieto JA, Miguel M. Contact dermatitis from benzoxonium chloride. Contact dermatitis 1999; 41: 53-54. Go to original source... Go to PubMed...
  8. Informace o účinné látce Dequalinium, http://pubchem.ncbi.nlm.nih.gov, 24. 2. 2009.
  9. Český lékopis 2005. Praha: Grada Publishing a.s., 2005: 269-303, 855-873.
  10. Hoang T, Jorgensen MG, Keim RG, Pattison AM, Slots J. Povidone-iodine as a periodontal pocket disinfectant. J Period Res 2003; 38: 311-317. Go to original source... Go to PubMed...
  11. Gehlen I, Netuschil L, Georg T, et al. Influence of a 0.2% Chlorhexidine Mouthrinse on Plaque Regrowth in Orthodontic Patients. J Orofac Orthoped 2000; 61: 138-148. Go to original source... Go to PubMed...
  12. Bruhn G, Netuschil L, Richter S, Brecx M, Hoffmann T. Effect of a toothpaste containing triclosan on dental plaque, gingivitis, and bleeding on probing - an investigation in periodontitis patients over 28 weeks. Clin Oral Invest 2002; 6: 124-127. Go to original source... Go to PubMed...
  13. Sreenivasan PK, Gaffar A. Antibacterials as anti-inflammatory agents: Dual action agents for oral health. Antonie van Leeuwenhoek 2008; 93: 227-239. Go to original source... Go to PubMed...
  14. Löber G, Hoffmann H. Ambazone as a membrane active antitumor drug. Biophys Chem 1990; 35: 287-300. Go to original source... Go to PubMed...
  15. Verschueren K. Handbook of Environmental Data on Organic Chemicals. 4. vyd. John Wiley & Sons, 2001. 21. González-García A, Diniz-Freitas M, Gándara-Vila P, et al. Triamcinolone acetonide mouth rinses for treatment of erosive oral lichen planus: efficacy and risk of fungal over-infection. Oral Dis; 2006; 12: 559-565. Go to original source...
  16. Kolektiv autorů. Remedia Compendium. 2. vyd. Praha: Panax, 1997: 663 s.
  17. Cheng KKF. Children's acceptance and tolerance of chlorhexidine and benzydamine oral rinses in the treatment of chemotherapy-induced oropharyngeal mucositis. Eur J Oncol Nurs 2004; 8: 341-349. Go to original source... Go to PubMed...
  18. Quane PA, Graham GG, Ziegler, JB. Pharmacology of benzydamin. Inflammopharmacology 1998; 6: 95-107. Go to original source... Go to PubMed...
  19. Chowdhury B, Adak M, Bose SK. Flurbiprofen, a unique non-steroidal anti-inflammatory drug with antimicrobial activity against Trichophyton, Microsporum and Epidermophyton species. Lett Appl Microbiol 2003; 37: 158-161. Go to original source... Go to PubMed...
  20. Moreland LW. Rheumatology and Immunology Therapy. Berlin Heidelberg: Springer, 2004: 923 s. Go to original source...
  21. Sharma NC, Galustians HJ, Qaqish J, et al. Antiplaque and antigingivitis effectiveness of a hexetidine mouthwash. J Clin Periodontol 2003; 30: 590-594. Go to original source... Go to PubMed...
  22. Singh S. Preparation and Evaluation of Buccal Bioadhesive Films Containing Clotrimazole. Amer Assoc Pharm Sci 2008; 9: 660-667. Go to original source... Go to PubMed...
  23. Suzuki O, Watanabe K. Drugs and Poisons in Humans: A Handbook of Practical Analysis. Berlin Heidelberg: Springer, 2005: 407-413. Go to original source...
  24. Vermerie, N, Malbrunot C, Azar M, Arnaud P. Stability of nystatin in mouthrinses; effect of pH, temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity. Pharm World Sci 1997; 19: 197-201. Go to original source... Go to PubMed...
  25. Van Leeuwen MR, Golovina EA, Dijksterhuis, J. The polyene antimycotics nystatin and filipin disrupt the plasma membrane, whereas natamycin inhibits endocytosis in germinating conidia of Penicillium discolor. J Appl Microbiol 2009, in press. Go to original source... Go to PubMed...
  26. Pizzo G, Giuliana G, Milici M, D'Angelo M. Effect of antimicrobial mouthrinses on the in vitro adhesion of Candida albicans to human buccal epithelial cells. Clin Oral Invest 2001; 5: 172-176. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.